Home  >  News
you can get e-magazine links on WhatsApp. Click here
Diagnostics + Font Resize -

MedGenome charts inorganic growth path in East India with the acquisition of stake in GenX Diagnostics

Our Bureau, Bengaluru
Wednesday, July 10, 2024, 15:50 Hrs  [IST]

MedGenome, a genomics-driven diagnostics and research services company, announced that it has acquired a stake in GenX Diagnostics, a leading diagnostic lab chain in Odisha.
GenX Diagnostics has been recognized for its unwavering commitment to healthcare excellence. MedGenome is a market leader in the Indian genetic diagnostics market, and through this partnership, GenX Diagnostics and MedGenome will leverage their combined expertise to deliver superior healthcare services, ensuring the people of Odisha have access to the best diagnostic and genomic solutions available, said the press communication note.
Dr Vedam Ramprasad, PhD, CEO, MedGenome, said, "With the acquisition of a stake in GenX Diagnostics, MedGenome will expand its market presence and product portfolio of over 1,300 tests in order to cater to a wider population base more effectively. It further aims to expand our network in Tier 2 and Tier 3 cities in India by driving deeper penetration, new market development, and bringing new tests to the market. With a focus on positioning Indian genomics globally, we develop solutions that cater to diverse markets worldwide.”
"This strategic collaboration aims to enhance healthcare services in the region, providing comprehensive and cutting-edge diagnostic solutions. We are committed to bringing sophisticated and advanced healthcare solutions to the people of Odisha. By combining our extensive product portfolio with MedGenome’s omics solutions, we will empower clinicians and consumers in Eastern India with the best diagnostic tools available,” said Dr. Biswajit Mohanty, GenX Diagnostics, Bhubaneswar.


* Name :     
* Email :    
  Website :  
Copyright © 2024 Saffron Media Pvt. Ltd | twitter